Advarra aims to accelerate pediatric trials in an agreement

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/shironosov)
(Image: Getty/shironosov)

Related tags: advarra, Pediatrics, Clinical trial, Clinical research, Clinical trial sites, Clinical trial site, Irb

Advarra will provide IRB services to the Institute for Advanced Clinical Trials for Children’s pediatric clinical trial site network.

The institutional review board (IRB) service provider will work with the Institute for Advanced Clinical Trials (I-ACT) for Children as it grows its trial site network, which currently includes 44 pediatric research sites in the US.

I-ACT for Children aims to accelerate biomedical innovation for child-centered clinical trial networks and stakeholders to accelerate site startup and completion of global pediatric studies. Pat Donnelly, CEO of Advarra told us that the network is focusing specifically on pediatrics to accelerate the establishment of safety and effectiveness data for approved and unapproved treatments.

Which Laura Gordon, CEO of I-ACT for Children, said in a statement that providing central IRB services as part of the site network is an imperative aspect of making pediatric trials more efficient.

He added that the network is continuing to add patients, investigators, and caregivers to provide independent guidance on developing the most respectful pediatric plans and protocols possible.

The US Food and Drug Administration (FDA) requires specific additional protections to be considered in pediatric trials, “this includes determining the specific level of risk presented, the prospect of direct benefit, and determining whether assent is necessary, and if so, how it’s documented,”​ said Donnelly.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars